SRD5A1: Steroid 5 Alpha-Reductase 1

Key enzyme in androgen metabolism and steroid hormone conversion

Gene Information Card

Symbol SRD5A1
Full Name Steroid 5 Alpha-Reductase 1
Gene Type Protein coding
Chromosomal Location 5p15.31
NCBI Gene ID 6715 ncbi.nlm.nih.gov/gene/6715
Ensembl ID ENSG00000145545
UniProt ID P18405
OMIM ID 184753
HGNC ID 11284
Aliases 3-oxo-5α-steroid 4-dehydrogenase 1, S5AR1, SRD5A1L

Description

SRD5A1 encodes steroid 5 alpha-reductase 1, an enzyme that catalyzes the conversion of testosterone into the more potent androgen dihydrotestosterone (DHT). This enzyme is expressed in various tissues including skin, liver, and prostate, and plays a critical role in androgen signaling, sexual differentiation, and hair growth. Mutations and altered expression of SRD5A1 are associated with disorders of sexual development, benign prostatic hyperplasia, and prostate cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Benign prostatic hyperplasia Increased SRD5A1 activity elevates DHT levels, promoting prostate cell proliferation ClinVar, OMIM
Prostate cancer Overexpression of SRD5A1 contributes to androgen-dependent tumor growth COSMIC, NCBI
Androgenetic alopecia Enhanced conversion of testosterone to DHT in scalp follicles leads to hair miniaturization OMIM
5-alpha-reductase deficiency (partial) Loss-of-function mutations reduce DHT synthesis, impairing male sexual development OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Prostate 12.3 Medium
Liver 8.7 Medium
Skin 6.5 Low
Adrenal gland 4.2 Low
Testis 3.1 Low
Cell Line Expression
Cell Line nTPM Notes
LNCaP (prostate cancer) 15.2 High expression
HepG2 (liver) 9.8 Moderate expression
HaCaT (keratinocyte) 5.4 Low expression
MCF-7 (breast cancer) 2.1 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.680G>A (p.Arg227Gln) Missense <0.1% Reduced enzyme activity; associated with partial 5-alpha-reductase deficiency
c.737G>A (p.Arg246Gln) Missense <0.1% Loss of function; impaired DHT synthesis
c.1A>G (p.Met1Val) Start loss <0.1% Complete loss of protein expression
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg227Gln, p.Arg246Gln) reduce or abolish enzymatic activity, leading to decreased DHT levels and impaired androgen signaling.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in SRD5A1.

Dominant Negative (DN)

No evidence of dominant-negative effects for SRD5A1 mutations.

Gene Ontology (GO)

• GO:0003854 - 3-oxo-5α-steroid 4-dehydrogenase activity • GO:0006702 - androgen biosynthetic process
• GO:0005783 - endoplasmic reticulum membrane • GO:0016021 - integral component of membrane
• GO:0042446 - hormone biosynthetic process

Pathways

Androgen biosynthesis (Reactome: R-HSA-196054)
Metabolism of steroids (Reactome: R-HSA-8957322)
Prostate cancer (KEGG: hsa05215)

Protein Summary

SRD5A1 is a 259-amino acid microsomal protein with a molecular weight of approximately 29.5 kDa. It contains a NADPH-binding domain and a steroid-binding domain, and functions as a homodimer. The enzyme reduces the double bond at the 4-5 position of steroid substrates, converting testosterone to DHT. It is inhibited by finasteride and dutasteride, which are used clinically for benign prostatic hyperplasia and androgenetic alopecia.

Related Products

Product name Cat.No. Species Gene ID
SRD5A1 Knockout HEK293 Cell Line EDJ-KQ2660 Human 6715 Details Get a Quote
SRD5A1 Knockout A-549 Cell Line EDJ-KQ23441 Human 6715 Details Get a Quote
SRD5A1 Knockout HCT 116 Cell Line EDJ-KQ23442 Human 6715 Details Get a Quote
SRD5A1 Knockout HeLa Cell Line EDJ-KQ23443 Human 6715 Details Get a Quote
SRD5A1 Knockout HAP1 Cell Line EDC07946 Human 6715 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: